Literature DB >> 20580390

Persistence of viral infection despite similar killing efficacy of antiviral CD8(+) T cells during acute and chronic phases of infection.

Vitaly V Ganusov1, Aron E Lukacher, Anthony M Byers.   

Abstract

Why some viruses establish chronic infections while others do not is poorly understood. One possibility is that the host's immune response is impaired during chronic infections and is unable to clear the virus from the host. In this report, we use a recently proposed framework to estimate the per capita killing efficacy of CD8(+) T cells, specific for the polyoma virus (PyV), which establishes a chronic infection in mice. Surprisingly, the estimated per cell killing efficacy of PyV-specific effector CD8(+) T cells during the acute phase of the infection was very similar to the efficacy of effector CD8(+) T cells specific to lymphocytic choriomeningitis virus (LCMV-Armstrong), which is cleared from the host. Our results suggest that persistence of PyV does not result from the generation of an inefficient PyV-specific CD8(+) T cell response, and that other host or viral factors are responsible for the ability of PyV to establish chronic infection. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580390      PMCID: PMC2922917          DOI: 10.1016/j.virol.2010.05.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

Review 1.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Cytotoxic T-cell memory without antigen.

Authors:  L L Lau; B D Jamieson; T Somasundaram; R Ahmed
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

3.  Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

Authors:  A U Neumann; N P Lam; H Dahari; D R Gretch; T E Wiley; T J Layden; A S Perelson
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

4.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.

Authors:  S Oehen; K Brduscha-Riem
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

5.  Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology.

Authors:  P Aichele; K Brduscha-Riem; S Oehen; B Odermatt; R M Zinkernagel; H Hengartner; H Pircher
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

6.  Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus.

Authors:  Z Grossman; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

8.  Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.

Authors:  A E Lukacher; J M Moser; A Hadley; J D Altman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

9.  Phylogenetics, evolution, and medical importance of polyomaviruses.

Authors:  Andi Krumbholz; Olaf R P Bininda-Emonds; Peter Wutzler; Roland Zell
Journal:  Infect Genet Evol       Date:  2009-04-18       Impact factor: 3.342

10.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  10 in total

1.  On the role of CD8 T cells in the control of persistent infections.

Authors:  Sean P Stromberg; Rustom Antia
Journal:  Biophys J       Date:  2012-10-16       Impact factor: 4.033

2.  Comparison of cytotoxic T lymphocyte efficacy in acute and persistent lymphocytic choriomeningitis virus infection.

Authors:  Frederik Graw; Kirsten Richter; Annette Oxenius; Roland R Regoes
Journal:  Proc Biol Sci       Date:  2011-03-30       Impact factor: 5.349

3.  Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.

Authors:  Frederik Graw; Roland R Regoes
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

4.  Virus replication strategies and the critical CTL numbers required for the control of infection.

Authors:  Andrew J Yates; Minus Van Baalen; Rustom Antia
Journal:  PLoS Comput Biol       Date:  2011-11-17       Impact factor: 4.475

5.  How is the effectiveness of immune surveillance impacted by the spatial distribution of spreading infections?

Authors:  Ulrich D Kadolsky; Andrew J Yates
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

6.  Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities.

Authors:  Victor Garcia; Kirsten Richter; Frederik Graw; Annette Oxenius; Roland R Regoes
Journal:  PLoS Comput Biol       Date:  2015-05-01       Impact factor: 4.475

7.  Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo.

Authors:  Thea Hogan; Ulrich Kadolsky; Sim Tung; Benedict Seddon; Andrew Yates
Journal:  PLoS Comput Biol       Date:  2014-09-18       Impact factor: 4.475

8.  Mathematical modeling reveals kinetics of lymphocyte recirculation in the whole organism.

Authors:  Vitaly V Ganusov; Jeremy Auerbach
Journal:  PLoS Comput Biol       Date:  2014-05-15       Impact factor: 4.475

9.  Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice.

Authors:  Margaret M McDaniel; Nitin Krishna; Winode G Handagama; Shigetoshi Eda; Vitaly V Ganusov
Journal:  Front Microbiol       Date:  2016-06-14       Impact factor: 5.640

10.  Rates of CTL killing in persistent viral infection in vivo.

Authors:  Marjet Elemans; Arnaud Florins; Luc Willems; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2014-04-03       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.